This course will provide an intensive, topics-based review of basic science topics pertinent to the clinical practice of veterinary oncology. The course will feature in-depth reviews of several topics of general interest to clinical oncology, as well as a keynote lecture series describing the scientific rationale for several specific emerging therapeutic options for treating small animal cancers. The course is tailored to be of interest to practicing diplomates as well as candidates preparing for the oncology certifying exam.

By the end of the course, you will be able to:

1. Demonstrate proficiency in recommending the use of molecular testing and functional imaging studies for diagnosis and prognostication in small animal cancer patients.
2. Describe common clinical trial designs involving cancer patients, as well as the objectives, limitations, and interpretation of results of each trial design.
3. Describe the interaction of cancer development with the immune system, and how the immune system can be harnessed in cancer therapy.
4. Describe the indications, technical specifications, and adverse events associated with hematopoietic stem cell transplantation in small animals with hematologic malignancies.
5. Identify cancer-bearing animals that may be candidates for new and emerging therapies, and be able to critically evaluate the utility of these therapies for specific small animal patients.

RACE Application Status:

This program has been approved for 16 hours of continuing education credit in jurisdictions which recognize RACE approval.